HEALTH● LOWJul 29 · Jul 29, 2026, 5:47 PM
Allogene rises as FDA offers Fast Track, RMAT tags to cell therapy
Seeking Alpha Tech
Allogene's stock rose after the FDA granted Fast Track and RMAT designations to its cell therapy. This indicates expedited regulatory review for a potentially significant medical treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoHeartbreaking new 9 / 11 data reveals first responder cancer deaths now DOUBLE people killed in terror attacks 25yrs onthe-sun.comHEALTH1h agoCalifornia next governor faces destabilizing surge in uninsured – Whittier Daily Newswhittierdailynews.com · United StatesHEALTH1h agoLonger hospital wait times as health feud deepensbegadistrictnews.com.au · AustraliaHEALTH2h agoZamfara gov’t overhauls healthcare delivery system, begins digitisation of general hospitalsVanguard Nigeria